Assignee
VYLUMA INC
US·8 granted patents·6 pending applications·6 citations·filing 2020–2024
Top patents by PatentIndex Score
14 records- 0194US11642338B2Atropine pharmaceutical compositionsVYLUMA INC·Filed 2021·Granted May 9, 2023·2 cites·20 claims
- 0293US11707458B2Atropine pharmaceutical compositionsVYLUMA INC·Filed 2020·Granted Jul 25, 2023·2 cites·20 claims
- 0392US11464769B2Atropine pharmaceutical compositionsVYLUMA INC·Filed 2020·Granted Oct 11, 2022·2 cites·20 claims
- 0491US2024342154A1Atropine Pharmaceutical CompositionsVYLUMA INC·Filed 2024·Application pending·0 cites
- 0588US12036217B2Atropine pharmaceutical compositionsVYLUMA INC·Filed 2023·Granted Jul 16, 2024·0 cites·20 claims
- 0682USRE50040EAtropine pharmaceutical compositionsVYLUMA INC·Filed 2022·Granted Jul 16, 2024·0 cites·20 claims
- 0776US11730727B2Atropine pharmaceutical compositionsVYLUMA INC·Filed 2020·Granted Aug 22, 2023·0 cites·20 claims
- 0876US11730728B2Atropine pharmaceutical compositionsVYLUMA INC·Filed 2020·Granted Aug 22, 2023·0 cites·22 claims
- 0967US11273141B2Low-dose carbachol compositions and methods for treatment of night vision disturbanceVYLUMA INC·Filed 2021·Granted Mar 15, 2022·0 cites·10 claims
- 1065US2026083720A1Childhood Atropine For Myopia ProgressionVYLUMA INC·Filed 2023·Application pending·0 cites
- 1165US2022160674A1Low-Dose Carbachol Compositions And Methods For Treatment Of Night Vision DisturbanceVYLUMA INC·Filed 2022·Application pending·0 cites
- 1257US2024139136A1Methods and formulations for topical administration of gabapentinoidsVYLUMA INC·Filed 2022·Application pending·0 cites
- 1354US2023301993A1Low-Dose Ophthalmic Compositions and MethodsVYLUMA INC·Filed 2021·Application pending·0 cites
- 1453US2024156724A1Multi-Dose Container for Ophthalmic CompositionsVYLUMA INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →